Ethics Approval

All study procedures were performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments. Informed patient consent was obtained for this work. The authors confirm that they have read the journal’s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.

Consent to Participate

Written informed consent was obtained from the participant included in the study.

Consent for Publication

The authors affirm that the participant provided informed consent for publication of the images and videos.

Conflict of Interest

The authors declare that they have no conflict of interest related to the research covered in this article. Dr. Luca Marsili has received honoraria from the International Association of Parkinsonism and Related Disorders (IAPRD) Society for social media and web support.

Dr. Alberto J. Espay has received grant support from the NIH and the Michael J Fox Foundation; personal compensation as a consultant/scientific advisory board member for Abbvie, Neuroderm, Neurocrine, Amneal, Adamas, Acadia, Acorda, Kyowa Kirin, Sunovion, Lundbeck, and US WorldMeds; publishing royalties from Lippincott Williams & Wilkins, Cambridge University Press, and Springer; honoraria from US WorldMeds, Acadia, and Sunovion. Dr. Espay is cofounder of REGAIN Therapeutics and owner of a provisional patent on compositions and methods for treatment and/or prophylaxis of proteinopathies. Dr. Marcelo A. Kauffman is an employee of the CONICET and has received grant support from the Ministry of Science and Technology of Argentina and the Ministry of Health of Buenos Aires. Drs. Davies, Gilthorpe, Williams, and Porollo have nothing to report.